As mentioned by Todd Goldstein, director of design and innovation at Northwell, Yahoo Finance, “First it was the kits, then it became the reagents [in short supply], then it became the swabs. We couldn’t print the kits or the reagents. It’s tough; everyone wants the same supplies at the same time.”
This entry was posted in 3D /4D Printing Medical Technology/Dental/Orthopedics/ Pharmaceuticals/ Implants/ Invisiline/Dentures/ Virtual Reality., 3D Printing 4D Printing's Network of Research/ Artificial Intelligence., 3D Printing/4D Printing /Biotechnology/Robotics., 3D/4D/5D Printing emergence., Policy. and tagged 3D printing and coronavirus testing, and Parts During the COVID-19 Pandemic, FAQs on 3D Printing of Medical Devices, FDA, How 3D-printing is playing a role in coronavirus testing, Northwell, Todd Goldstein, Yahoo Finance.